In the virtual space, various pseudo-oncological cancer therapies are promoted on the basis of examples such as “I know X or Y who followed intermittent fasting, or a ketogenic diet, or who has eliminated the animal protein altogether, or who used alkaline water, who took this mushrooms or that miracle powder and cancer has vanished”.
Although the word „cancer“ covers a multitude of localisations, loco-regional or distance disorders, immunohistochemistry and genetic mutations – and therefore completely different evolutions and treatments from one patient to another, even for patients with the same localisation – pseudo-oncology sells all sorts of panacea good for any type of cancer one might have.
We do not know what happens long-term to the patient who is using complementary-integrative “medicine” because these systems are not legally required to monitor patients long-term. By law, such pseudo-oncology products and strategies can be sold based on the supposition that they are safe. The safety is not tested or addressed in any way, it is assumed.
– Still, can we put the equal sign between tumour disappearance and cancer cure?
Scientifically, the disappearance of the tumour is called “complete pathological response” – and in allopathic medicine can be obtained surgically or by chemotherapy.
The hypothesis that tumour disappearance means cancer cure has been contradicted for decades by the fact that the surgical removal of the tumour does not necessarily mean that the cancer is cured (Haagensen et al., 1951).
Also, if surgical removal of cancer does not necessarily mean healing, the same is true sometimes in the case of tumour disappearance by chemotherapy (Cortazar et al., 2014).
For example, we know that patients with triple-negative breast cancer or HER2+ often respond very well to chemotherapy given immediately after diagnosis, obtaining tumor disappearance before surgery (therapeutic response called “pathologic complete response”), and that such response can sometimes be obtained even in multicenter tumours (Ataseven et al., 2015).
And according to the current scientific data we also know that the surgical intervention remains important even after obtaining pathologic complete response to neoadjuvant chemotherapy. (Ring et al., 2003; Clouth et al., 2007; Daveau et al., 2011).
So, the complete disappearance of the tumour does not mean curing cancer, we know that for a long time, and we do not hide under the carpet that we know.
The honest treatment efficiency evaluation is the essential difference between complementary-integrative “medicine” and allopathic medicine.
In spite of the various personal examples quoted and promoted as proof that you can naturally cure your own cancer without oncological treatment, based on the available scientific data:
- the ketogenic diet is not recommended for any patient with cancer diagnosis (Erickson et al., 2017)
- administration of various dietary supplements during chemotherapy is associated with decreased survival (Smith et al., 2016)
- vitamin C administration does not have antitumoral effect, even at huge doses of 70, 90 or 110 g/m2 administered intravenously (Hooffer et al., 2008)
- antioxidants administration during oncological treatment is contraindicated (Seifield et al., 2003)
- antioxidants may increase the metastasis risk (Herraiz et al., 2016)
Unlike complementary-integrative medicine, oncology is based on the objective treatment efficiency evaluation:
- in the short-term – the periodic evaluation of the pathological response is essential for each patient’s treatment individualisation
- in the long-term – the regular clinical and imagistic evaluation are essential for the early diagnosis of any possible metastasis or recurrence that might occur after treatment even in the case of patients that actually obtained pathologic complete response
So, if you are an oncological patient and you are tempted to try a “miracle” that “cured” another person’s cancer “naturally”, ask yourself at least these three questions:
- Has the cured cancer been objectively evaluated in an imagistic, histopathological or clinical way? Or the disappearance of the tumour is simply assumed based on the fact that the patient “feels better”?
- Compared to you, did the person have the same cancer location, the same type of cancer and the same number of tumours?
- Compared to you, did the person have the same lymph node or the same metastases?
- Compared to you, did that person have the same age, same sex and identical family history?
- Compared to you, did the person suffer from the same diseases other than cancer?
- Compared to you, did that person gained or lose weight after diagnosis?
- Do you know what happened to that person after 10, 15 – or at least 5 years?
I know I wrote more than 3 questions. But there are so many differences even between two people with exactly the same immunohistochemical type of cancer that I can still write so many other questions.
Cocaine is also natural and it has side effects.
The tumour disappearance should be monitored long, loong, looong time to be able to say that patient is cured – which is why the clinical and radiological controls that are regularly performed long-term after cancer disappearance are absolutely essential.
Ataseven, Beyhan, et al. “Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy.” Annals of surgical oncology 22.4 (2015): 1118-1127.
Clouth, B., et al. “The surgical management of patients who achieve a complete pathological response after primary chemotherapy for locally advanced breast cancer.” European Journal of Surgical Oncology (EJSO) 33.8 (2007): 961-966.
Cortazar, Patricia, et al. “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.” The Lancet 384.9938 (2014): 164-172.
Daveau, Caroline, et al. “Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?.” International Journal of Radiation Oncology* Biology* Physics 79.5 (2011): 1452-1459.
Erickson, N., et al. “Systematic review: isocaloric ketogenic dietary regimes for cancer patients.” Medical Oncology 34.5 (2017): 72.
Haagensen, C. D., and Arthur Purdy Stout. “Carcinoma of the breast. III. Results of treatment, 1935-1942.” Annals of surgery 134.2 (1951): 151.
Herraiz, Cecilia, Eva Crosas-Molist, and Victoria Sanz-Moreno. “Reactive oxygen species and tumor dissemination: Allies no longer.” Molecular & cellular oncology 3.2 (2016): e1127313.
Hoffer, L. J., et al. “Phase I clinical trial of iv ascorbic acid in advanced malignancy.” Annals of Oncology 19.11 (2008): 1969-1974.
Ring, Alistair, et al. “Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?.” Journal of clinical oncology 21.24 (2003): 4540-4545.
Seifried, Harold E., et al. “The antioxidant conundrum in cancer.” Cancer Research 63.15 (2003): 4295-4298.
Smith, Peter J., et al. “Complementary and alternative medicine use by patients receiving curative‐intent chemotherapy.” Asia‐Pacific Journal of Clinical Oncology 12.3 (2016): 265-274.